tiprankstipranks
Trending News
More News >
Origin Therapeutics Holdings, Inc. (TSE:SPLY)
:SPLY
Canadian Market

Origin Therapeutics Holdings, Inc. (SPLY) Income Statement

Compare
3 Followers

Origin Therapeutics Holdings, Inc. Income Statement

Last quarter (Q3 2024), Origin Therapeutics Holdings, Inc.'s total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Origin Therapeutics Holdings, Inc.'s net income was $-574.15K. See Origin Therapeutics Holdings, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 23Sep 22Sep 21
Total Revenue
$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ ―
EBITDA
$ ―$ -1.45M$ -1.19M
Operating Income
$ ―$ -1.21M$ -1.19M
Other Income/Expenses
$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―
Net Income
$ -6.31M$ -1.45M$ -845.51K
Per Share Metrics
Basic EPS
$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Origin Therapeutics Holdings, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis